In short
- 🔑 Breast reconstruction is not aesthetic surgery: it is reconstructive surgery, with a medical indication, within a cancer pathway and with a multidisciplinary team behind it.
- A breast cancer under investigation or under treatment, without an oncology plan that allows for it, is a contraindication to an aesthetic augmentation.
- ⚠️ Radiotherapy is the factor that most changes the outlook for an implant, and it has been measured in two independent meta-analyses: capsular contracture is more than five times as likely in an irradiated breast.
- And not only contracture: failure of the reconstruction (a little more than twice as likely) and overall complications also rise, and satisfaction and the likelihood of a good aesthetic result fall.
- Carrying a BRCA mutation is not an indication for an aesthetic augmentation: it opens a different oncogenetic conversation, with intensive surveillance or risk-reducing surgery, and that decision is not taken at an aesthetic surgery consultation.
- Having a family history without a known mutation does not contraindicate an aesthetic augmentation, and it does change the conversation about screening.
- 🔑 And one thing that applies to all of them: an implant does not increase the risk of breast cancer. The FDA states expressly that it has found no association.
An aesthetic augmentation and a breast reconstruction are not the same thing, even though an implant is used in both. They have a different indication, a different pathway, different funding and, above all, a clinical context that completely changes what can be expected.
This page separates the three situations that arrive mixed together at an aesthetic surgery consultation: having had cancer, carrying a risk mutation and having a family history without a known mutation.
⚠️ This page does not replace your oncology team. If you are under investigation, under treatment or under follow-up for breast cancer, any decision about implants is taken with them.
Situation 1: you have had breast cancer
First of all: which operation are we talking about
It is not the same question to say “I want to reconstruct the breast that was removed” as to say “I want to enlarge the breast I still have”.
- Reconstruction of a breast after mastectomy or after breast-conserving surgery: it is reconstructive surgery, it forms part of the cancer pathway and it is decided with the team treating you. Where that information starts is the reconstructive surgery area.
- Symmetrisation of the other breast: it too forms part of the reconstructive process.
- Aesthetic augmentation of a healthy breast in someone with a history of cancer: that is another matter, and it is what the rest of this section is about.
When it is a contraindication
A cancer under investigation or under active treatment, without an oncology plan that allows for the surgery. It is not a matter of generic caution: elective surgery can interfere with the treatment schedule, with the interpretation of investigations and with the disease itself.
Who decides that is not the plastic surgeon on their own: it is a decision taken with the oncology team.
And when the history changes what can be expected
Here is the part almost never explained with figures: if that breast has had radiotherapy, an implant behaves differently.
Two independent meta-analyses quantify it, both on immediate implant reconstruction after mastectomy:
| Meta-analysis of 6,757 patients | Meta-analysis of 5,314 patients | |
|---|---|---|
| Capsular contracture | OR 5.99 (3.12-11.47) | OR 5.26 (2.73-10.13) |
| Failure of the reconstruction | OR 2.57 (1.55-4.26) | OR 2.59 (1.46-4.62) |
| Overall complications | OR 2.52 (1.68-3.79) | OR 3.45 (2.62-4.54) |
| Patient satisfaction | OR 0.29 (0.16-0.52) | — |
| A good aesthetic result | OR 0.25 (0.12-0.52) | — |
🔑 Two separate reviews, with more than twelve thousand patients between them, agree that an irradiated breast is more than five times as likely to develop capsular contracture, more than twice as likely to have the reconstruction fail and less than a third as likely to leave the patient satisfied.
⚠️ How to read it precisely. These figures come from reconstruction after mastectomy with post-operative radiotherapy, not from aesthetic augmentation of a breast irradiated for some other reason. They are not the same situation. What carries over is the principle: irradiated tissue behaves differently with an implant inside it, and that has to be put on the table beforehand and not afterwards.
And the authors themselves add the qualification that belongs here: radiotherapy remains the standard adjuvant treatment where it is indicated. The conclusion is not to avoid radiotherapy: it is to plan the reconstruction knowing this.
Follow-up, which does not change
With a history of cancer, follow-up rules over everything else. An implant must not interfere with it, and that is why:
- You have to say that you have implants when booking any imaging test, so that the right views are used.
- The cancer follow-up schedule is set by your team, not by the clinic where you have aesthetic surgery.
- Implant check-ups are additional, not a substitute. They are on their own page.
Situation 2: you carry a BRCA mutation
It is an oncogenetic conversation, not an aesthetic one.
Carrying a mutation in BRCA1 or BRCA2 means an increased risk of breast and ovarian cancer, and it opens a range of decisions —intensified surveillance, chemoprevention, risk-reducing surgery— that are taken in a genetic counselling unit and with a multidisciplinary team.
🔑 A risk-reducing mastectomy with reconstruction is not a breast augmentation, even though there is an implant in both. It is preventive surgery with a medical indication, a different consent form and a different pathway.
⚠️ And there is something worth saying plainly: an aesthetic augmentation does not reduce the risk of breast cancer. It neither increases it —the FDA has found no association between silicone gel implants and breast cancer— nor lowers it. It is not a preventive measure for anything.
How it is handled here
Patients with a history of cancer who come about breast surgery are seen, and breast reconstruction is performed. The pathway is simple and worth stating because it is what nobody explains: the assessment is done by the plastic surgeon, and if the case needs another specialist’s input, it is the plastic surgeon who coordinates it. It is not for you to go stringing appointments together.
And what documentation is needed. If the disease is completely resolved, you are asked about it and the case is assessed without further formalities. If something is outstanding or there is any doubt, it is looked into and whichever reports that particular case requires are requested. 🔑 What is always essential is a breast ultrasound before surgery.
Situation 3: you have a family history, without a known mutation
It is the commonest of the three situations and the least problematic.
It does not contraindicate an aesthetic augmentation. A family history with no identified mutation does not change the surgical indication.
What it does change is the conversation about screening:
- You may be due earlier or more intensive screening than the general population. That is determined by your doctor according to the family pattern, not by the aesthetic clinic.
- Breast imaging before surgery carries more weight, both to rule out findings and to put the starting point on record.
- And with implants, the screening remains the same, with the technique adapted: displacement views to see the tissue the implant hides. It is in the page on living with implants.
⚠️ If your family pattern is striking —several cases, young ages, associated ovarian cancer, breast cancer in a man—, that is a reason to consult your doctor before considering aesthetic surgery. Not because it prevents surgery, but because there is a prior conversation worth having.
What applies to all three situations
A breast implant does not cause breast cancer. The FDA states it expressly:
“The FDA has not detected any association between silicone gel-filled breast implants and connective tissue disease, breast cancer or reproductive problems.”
And BIA-ALCL, which is associated with implants, is not a breast cancer: it is a lymphoma that arises in the capsule surrounding the implant. It is on its own page.
What an implant does do is change the technique of your mammogram, not your right to have one.
Book an appointment
You can book your own appointment. Pick the day and time from the free slots in the diary, in a panel that opens right here, without leaving this page.
Frequently asked questions
Can I have implants if I have had breast cancer?
It depends on the situation. A cancer under investigation or under treatment without an oncology plan that allows for the surgery is a contraindication. With the disease treated and under follow-up, the decision is taken with your oncology team, and the history changes what it is reasonable to expect — particularly if that breast had radiotherapy.
Is a reconstruction the same as a breast augmentation?
No. Reconstruction is reconstructive surgery, with a medical indication, within a cancer pathway and with a multidisciplinary team. An aesthetic augmentation is elective surgery on a healthy breast. Although an implant is used in both, they are not the same operation or the same pathway.
How much does radiotherapy worsen the result of an implant?
A good deal, and it has been measured. In two independent meta-analyses on immediate implant reconstruction, the irradiated breast was more than five times as likely to develop capsular contracture (OR 5.99 and 5.26), more than twice as likely to have the reconstruction fail, and significantly less likely to produce satisfaction and a good aesthetic result.
I am BRCA+. Should I have implants?
That is not the question that belongs at an aesthetic surgery consultation. Carrying a mutation opens a range of decisions —intensified surveillance, chemoprevention, risk-reducing surgery— that are taken in a genetic counselling unit. And an aesthetic augmentation does not reduce the risk of breast cancer.
My mother had breast cancer. Can I have surgery?
A family history without a known mutation does not contraindicate an aesthetic augmentation. What is worth settling beforehand is the conversation about which screening you are due, which your doctor determines according to the family pattern.
Do implants increase the risk of breast cancer?
No. The FDA states expressly that it has found no association between silicone gel implants and breast cancer. BIA-ALCL, which is associated with implants, is a lymphoma of the capsule, not a breast cancer.
Will I still be able to have mammograms?
Yes, and you should. What changes is the technique: specific displacement views are used to see the tissue the implant hides. All you have to do is say that you have implants when booking the appointment.
Sources
- Hong WJ, et al. The Effect of Previous Irradiation for Patients With Prosthetic Breast Reconstruction: A Meta-Analysis. Aesthetic Surgery Journal, 2021. PMID 33621335. — 19 studies with 6,757 patients: post-mastectomy radiotherapy was associated with a higher incidence of failure of the reconstruction (OR 2.57; 95% CI: 1.55-4.26), capsular contracture (OR 5.99; 3.12-11.47) and overall complications (OR 2.52; 1.68-3.79), and with a lower incidence of patient satisfaction (OR 0.29; 0.16-0.52) and of a good aesthetic result (OR 0.25; 0.12-0.52); the authors remind readers that radiotherapy remains the standard adjuvant treatment in the patients who need it.
- Pu Y, et al. The role of postmastectomy radiation therapy in patients with immediate prosthetic breast reconstruction: A meta-analysis. Medicine, 2018. PMID 29419662. — 15 comparative studies with 5,314 patients (1,069 with post-mastectomy radiotherapy against 4,245 without it): a statistically significant increase in overall complications (OR 3.45; 2.62-4.54), failure of the reconstruction (OR 2.59; 1.46-4.62) and capsular contracture (OR 5.26; 2.73-10.13) after radiotherapy.
- Risks and Complications of Breast Implants. U.S. Food and Drug Administration, updated 14 December 2023. fda.gov. — “The FDA has not detected any association between silicone gel-filled breast implants and connective tissue disease, breast cancer or reproductive problems”; chemotherapy and radiotherapy are among the causes of necrosis of breast tissue; calcifications around the implant can be mistaken for a cancer on a mammogram.
- Questions and Answers about Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). U.S. Food and Drug Administration. fda.gov. — BIA-ALCL is not a breast cancer but a non-Hodgkin lymphoma usually located in the fibrous capsule and in the fluid around the implant.
Book your consultation
If you have a personal or family history of cancer, the most useful thing you can bring to a first consultation is your report and your follow-up schedule. At our practice in Valencia we assess what fits your situation and what does not, and we also say when the conversation that belongs is a different one.
Clinical confirmation by the surgeon
Registration no. 46/4624077
Registration no. 46/4624503
